Lilly and Incyte say trial data showed 38% reduction in mortality by Day 28 for baricitinib plus SOC : by
By: Posted on
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.